48 related articles for article (PubMed ID: 15764294)
1. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions.
Vineis P; Veglia F; Anttila S; Benhamou S; Clapper ML; Dolzan V; Ryberg D; Hirvonen A; Kremers P; Le Marchand L; Pastorelli R; Rannug A; Romkes M; Schoket B; Strange RC; Garte S; Taioli E
Biomarkers; 2004; 9(3):298-305. PubMed ID: 15764294
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India.
Peddireddy V; Badabagni SP; Gundimeda SD; Mamidipudi V; Penagaluru PR; Mundluru HP
Eur J Med Res; 2016 Apr; 21():17. PubMed ID: 27090234
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of CYP1A1, GSTM1 and P53 genes in a unique Siberian population of Tundra Nentsi and its pharmacogenetic importance.
Duzhak TG; Osipova LP; Posukh OL; Chasovnikova OB; Ostashevskii VI; Lyakhovich VV
Int J Circumpolar Health; 2001 Apr; 60(2):228-34. PubMed ID: 11507974
[TBL] [Abstract][Full Text] [Related]
4. The association of GSTM1 deletion polymorphism with lung cancer risk in Chinese population: evidence from an updated meta-analysis.
Yang H; Yang S; Liu J; Shao F; Wang H; Wang Y
Sci Rep; 2015 Mar; 5():9392. PubMed ID: 25797617
[TBL] [Abstract][Full Text] [Related]
5. Association of Interactions between Metabolic 'Caretaker' Genes, p53, MDM2, and Tobacco Use with the Risk of Oral Cancer: A Multifactor Dimensionality Reduction Approach.
Singh RD; Patel KA; Patel JB; Patel PS
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1231-1237. PubMed ID: 37116145
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer andCYP1A1 orGSTM1 polymorphisms.
Oyama T; Kagawa N; Kim YD; Matsumoto A; Isse T; Kawamoto T
Environ Health Prev Med; 2003 Jan; 7(6):230-4. PubMed ID: 21432390
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: Application of the additive model for cancer.
Pérez-Morales R; Méndez-Ramírez I; Castro-Hernández C; Martínez-Ramírez OC; Gonsebatt ME; Rubio J
Genet Mol Biol; 2011 Oct; 34(4):546-52. PubMed ID: 22215955
[TBL] [Abstract][Full Text] [Related]
8. Association between the combined effects of GSTM1 present/null and CYP1A1 MspI polymorphisms with lung cancer risk: an updated meta-analysis.
Zhang WP; He XF; Ye XH
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32945337
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.
Wang X; Yue K; Hao LR
Int J Clin Exp Med; 2015; 8(8):11905-12. PubMed ID: 26550103
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
Li W; Song LQ; Tan J
Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
[TBL] [Abstract][Full Text] [Related]
11. Association between glutathione S-transferase T1 null genotype and risk of lung cancer: a meta-analysis of 55 studies.
Yang H; Shen X; Li B; Ma R
Tumour Biol; 2014 Mar; 35(3):2359-66. PubMed ID: 24189890
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects.
Zhou HF; Feng X; Zheng BS; Qian J; He W
Mol Biol Rep; 2013 Oct; 40(10):5713-21. PubMed ID: 24072652
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias.
López-Cima MF; Alvarez-Avellón SM; Pascual T; Fernández-Somoano A; Tardón A
BMC Cancer; 2012 Sep; 12():433. PubMed ID: 23013535
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of at-risk genotypes for genotoxic effects decreases with age in a randomly selected population in Flanders: a cross sectional study.
Ketelslegers HB; Godschalk RW; Gottschalk RW; Knaapen AM; Koppen G; Schoeters G; Baeyens WF; Nelen V; Geraedts JP; van Delft JH; Kleinjans JC; van Larebeke NA
Environ Health; 2011 Oct; 10():85. PubMed ID: 21975123
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China.
Jin Y; Xu H; Zhang C; Kong Y; Hou Y; Xu Y; Xue S
BMC Cancer; 2010 Aug; 10():422. PubMed ID: 20704749
[TBL] [Abstract][Full Text] [Related]
16. Preferential glutathione conjugation of a reverse diol epoxide compared with a bay region diol epoxide of benzo[a]pyrene in human hepatocytes.
Upadhyaya P; Hochalter JB; Balbo S; McIntee EJ; Hecht SS
Drug Metab Dispos; 2010 Sep; 38(9):1397-402. PubMed ID: 20547966
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study.
Varela-Lema L; Ruano-Ravina A; Juiz Crespo MA; Kelsey KT; Loidi L; Barros-Dios JM
J Oncol; 2008; 2008():741310. PubMed ID: 19259333
[TBL] [Abstract][Full Text] [Related]
18. Preferential glutathione conjugation of a reverse diol epoxide compared to a bay region diol epoxide of phenanthrene in human hepatocytes: relevance to molecular epidemiology studies of glutathione-s-transferase polymorphisms and cancer.
Hecht SS; Berg JZ; Hochalter JB
Chem Res Toxicol; 2009 Mar; 22(3):426-32. PubMed ID: 19187038
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking.
Kumar M; Agarwal SK; Goel SK
Mol Cell Biochem; 2009 Feb; 322(1-2):73-9. PubMed ID: 19009239
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology to better predict lung cancer risk.
Reid ME; Santella R; Ambrosone CB
Clin Lung Cancer; 2008 May; 9(3):149-53. PubMed ID: 18621624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
